Skip to main content

Indian Funding:

  • Eldercare platform Age Care Labs, which includes technology platform Emoha and care home chain for the elderly with dementia, Epoch, has raised $11 million in a pre-Series B round led by venture capital firms Rainmatter Capital and Gruhas

Global Funding:

  • Allara, a virtual care platform serving women of reproductive age with chronic hormonal conditions, has announced a $10M Series A funding round led by GV (Google Ventures).
  • AOA Dx, a biotech startup based in the United States, has successfully raised $17M to accelerate the development of its liquid biopsy test for ovarian cancer. This round was led by Good Growth Capital with participation from industry leading investors
  • The Institute for Excellence in Health Equity at NYU Langone Health has been awarded an NIH grant of $12.5M to initiate a digital intervention focused on the maternal mortality crisis in the United States.
  • MDisrupt has raised $3M in seed funding from The Venture Collective, Capita3, 3plus VC, Geek Ventures, and Mindshift Capital, among others.

FemTech News:

  • Menstrual cycle changes during the pandemic could be linked to shifts in behaviour and lifestyle rather than the virus itself, a study has found. The study, has shed light on the effects of the pandemic on women’s menstrual cycles, showing a significant correlation between the pandemic and changes in menstrual cycle characteristics, hormonal symptoms, and lifestyle habits.
  • Roughly 52 per cent of cervical cancer cases diagnosed between 2012 and 2015 survived, scientists have found after analysing data from Population Based Cancer Registries (PBCRs) across India.
  • Despite being a routine procedure at many hospitals, abortion is not mentioned by almost 80 percent of health system websites, a new study has found.A new report has revealed that a lack of disclosure may contribute to stigma around abortion procedures in the US.
  • A new blood test could detect ovarian cancer early, with up to 91 per cent accuracy, researchers have found. The recent study, has shown that the blood test may distinguish between cancerous and benign pelvic masses with up to 91 per cent accuracy, surpassing other commercially available tests.
  • A novel DNA biosensor developed by researchers from Chung-Ang University could help diagnose cervical cancer early. The electrochemical sensor, made of a graphitic nano-onion/molybdenum disulfide nanosheet composite, could detect with high specificity two high-risk types of HPV, HPV-16 and HPV-18, which are responsible for around 70& of all HPV-related cervical cancers.
  • Male infertility is a growing concern worldwide, prompting experts to call for urgent action from governments and healthcare systems. In a consensus report published in the journal Nature Reviews Urology, scientists led by the University of Melbourne have outlined recommendations to address this serious medical condition.
  • Automated insulin delivery should be rolled out to pregnant women with type 1 diabetes, according to a new research. A new study published today shows that the move could help pregnant women better manage their blood sugars compared to traditional insulin pumps or multiple daily injections.

FemTech India Partner Company News:

  • Lactamo was named as one of the finalists in Australia’s most prestigious business awards program – Telstra Business of Business Awards, 2024.
  • Dr. Simram Shamanur, Physician of Allo Health was featured by Femina India on the topic – Gender Inequality in Pleasure.
  • PeeSafe has a product sampling activity at airports managed by Adani group and showcases the products to travellers.
  • Gytree published a thought ware on “Neurotransmitter in Protein can improve your Mental Health”
  • FemVed is hosting a live enlightening discussion on “Living the Yoga Life: Beyond the Asanas” with Pooja Gandhi and Madira Chaudhary on October, 21st.

Global Companies:

  • Gynae Health startup Daye and clinical trial company Lindus Health have launched a clinical trial for a Diagnostic Tampon designed to allow women and assigned female at birth (AFAB) individuals to conduct HPV and STI tests in their homes.
  • Unprude, a new sex therapy app is now available in the Philippines, Singapore, Hong Kong, Indonesia, Thailand, South Korea, the U.S., and Canada.
  • Gals Bio, an Israeli firm, has launched Tulipon, a new menstrual product which provides menstrual care by merging the attributes of tampons and menstrual cups, ensuring both ease of use and sustainability. 
  • Fairtility, a transparent AI innovator powering reproductive care for improved outcomes, has announced that its AI decision support system, CHLO, has been successfully integrated with leading electronic medical record (EMR) platforms used in fertility clinics.
  • The US fertility benefits company WIN is to launch a new initiative to help women access perimenopause and menopause support.

Government News:

  • The National Pharmaceutical Pricing Authority (NPPA) has issued the draft ceiling price calculation for 10 formulations including significant reduction in prices of a brain cancer drug formulation to almost 70 per cent. 
  • The Union Ministry of Ayush has announced that the ‘Ayurveda Day’, scheduled to be on November 10, 2023 on the occasion of Dhanvantari Jayanti, will be celebrated internationally in about 100 countries across the globe.
  • The Directorate General of Trade Remedies (DGTR) has come to the conclusion that the domestic industry is not suffering any material injury due to imports of Metronidazole from China in an anti-dumping investigation case. The DGTR does not consider it appropriate to recommend levy of anti-dumping duty on the imports of Metronidazole from China.  

Drugs, Diagnostics, and Pharma:

  • Glenmark Pharmaceuticals Limited, a research-led, global pharmaceutical company, has launched in India the first triple-drug fixed-dose combination (FDC) of the widely used teneligliptin with dapagliflozin and metformin. 
  • Merck, announced that the US Food and Drug Administration (FDA) has approved Keytruda, Merck’s anti-PD-1 therapy, for the treatment of patients with non-small cell lung cancer (NSCLC) 
  • PharmaKure, a pharmaceutical company spun out from the University of Manchester, announces successful study results for a novel whole blood test for quantifying Alzheimer’s disease biomarkers. PharmaKure’s proprietary ALZmetrix blood test can identify blood-based biomarkers in patients with Alzheimer’s disease to provide early warning of cognitive decline.

Research, Insights, and Market Projections:

  • According to a recent study led by the All-India Institute of Medical Sciences (AIIMS), a staggering 95 percent of healthcare-associated infections, including bloodstream infections, ventilator pneumonia, and urinary tract infections, are attributed to medical devices.
  • Scientists have shed light on how the demanding schedules of night shift workers wreak havoc on their eating habits and overall health. The team of researchers focused their investigation on the adrenal gland, a vital organ responsible for producing glucocorticoid hormones that control metabolic processes and appetite. By manipulating the light and dark cues that govern our internal clock, the scientists induced a state of circadian misalignment akin to the disorienting effects of jet-lag.

Jobs on Board:

  • PeeSafe is looking for an E-Commerce Associate. PeeSafe is a  personal, sexual, menstrual hygiene expert.
  • Allo Health is looking for a Video Editor. Allo Health is India’s first digital health clinic for sexual well-being.

Today’s newsletter is brought to you by Navneet Kaur and Jayant Pal Singh

Leave a Reply